Primary Peritoneal Anaplastic Giant Cell Carcinoma: Case Report of an Unusual and Highly Malignant Mullerian Neoplasm (Case Study)

Primary Peritoneal Anaplastic Giant Cell Carcinoma: Case Report of an Unusual and Highly Malignant Mullerian Neoplasm (Case Study)

Primary peritoneal carcinoma (PPC) is a rare tumor and tends to occur in elderly women. (1) Like its ovarian counterpart, the tumor often presents with abdominal distention, pain, and pressure. (1,2) More than 90% of PPCs are papillary serous carcinomas. (1-3) Other much less common types of PPC include clear cell carcinoma, endometrioid carcinoma, mucinous […]

Williams Hematology Malignant Lymphoid Diseases

Williams Hematology Malignant Lymphoid Diseases

Leukemias and lymphoid diseases as only Williams can cover them Featuring content derived from Williams Hematology, Ninth Edition. this concise, full-color resource delivers comprehensive and current coverage of leukemias and lymphoid diseases. More than a sectional reprint, the book includes updated science and treatment recommendations not found in the 2015 release of Williams Hematology, Ninth […]

Fertility Preservation in Females with Malignant Disease-1: Causes, Clinical Needs and Indications/ Malignitesi Olan Kadinlarda Dogurganligin Korunmasi-1: Nedenler, Klinik Gereksinimler Ve Endikasyonlar (Report)

Fertility Preservation in Females with Malignant Disease-1: Causes, Clinical Needs and Indications/ Malignitesi Olan Kadinlarda Dogurganligin Korunmasi-1: Nedenler, Klinik Gereksinimler Ve Endikasyonlar (Report)

Introduction Cancer incidence is gradually increasing while deaths caused by malignant diseases decrease. When all female cancers are considered, despite an increase in the cancer incidence by 0.3% annually from 1987 to 1999, the death rates for all cancers combined decreased by 0.6% annually from 1992 to 1999 as a result of improvements in current […]

Advances in Malignant Hematology

Advances in Malignant Hematology

This comprehensive book captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes, molecular pathology, and cytogenetic, epigenetic and genomic changes has influenced the current outlook toward haematological malignancies. This recent and ongoing expansion of knowledge on malignant hematology has not previously been utilized to its full capacity due […]